84 related articles for article (PubMed ID: 19933721)
1. Oxidative stress and homocysteine metabolism in patients with lupus nephritis.
Moroni G; Novembrino C; Quaglini S; De Giuseppe R; Gallelli B; Uva V; Montanari V; Messa P; Bamonti F
Lupus; 2010 Jan; 19(1):65-72. PubMed ID: 19933721
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in kidney transplant patients.
Campise M; Bamonti F; Novembrino C; Ippolito S; Tarantino A; Cornelli U; Lonati S; Cesana BM; Ponticelli C
Transplantation; 2003 Nov; 76(10):1474-8. PubMed ID: 14657689
[TBL] [Abstract][Full Text] [Related]
3. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
5. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
[TBL] [Abstract][Full Text] [Related]
6. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study.
Abilés J; de la Cruz AP; Castaño J; Rodríguez-Elvira M; Aguayo E; Moreno-Torres R; Llopis J; Aranda P; Argüelles S; Ayala A; de la Quintana AM; Planells EM
Crit Care; 2006; 10(5):R146. PubMed ID: 17040563
[TBL] [Abstract][Full Text] [Related]
8. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
10. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
11. Plasma-induced endothelial oxidative stress is related to the severity of septic shock.
Huet O; Obata R; Aubron C; Spraul-Davit A; Charpentier J; Laplace C; Nguyen-Khoa T; Conti M; Vicaut E; Mira JP; Duranteau J
Crit Care Med; 2007 Mar; 35(3):821-6. PubMed ID: 17255877
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
13. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in normospermic men undergoing infertility evaluation.
Pasqualotto FF; Sharma RK; Kobayashi H; Nelson DR; Thomas AJ; Agarwal A
J Androl; 2001; 22(2):316-22. PubMed ID: 11229806
[TBL] [Abstract][Full Text] [Related]
15. Oxidative status in stable renal transplantation.
Minz M; Heer M; Arora S; Sharma A; Khullar M
Transplant Proc; 2006 Sep; 38(7):2020-1. PubMed ID: 16979986
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
[TBL] [Abstract][Full Text] [Related]
17. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
18. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.
Burling F; Ng J; Thein H; Ly J; Marshall MR; Gow P
Lupus; 2007; 16(10):830-7. PubMed ID: 17895308
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
20. Delayed lupus nephritis.
Varela DC; Quintana G; Somers EC; Rojas-Villarraga A; Espinosa G; Hincapie ME; McCune WJ; Cervera R; Anaya JM
Ann Rheum Dis; 2008 Jul; 67(7):1044-6. PubMed ID: 18413438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
